Colitis, Ulcerative - 30 Studies Found
| Completed |
: Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients : Colitis, Ulcerative : 2011-01-25 :
|
| Active, not recruiting |
: A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis : Colitis, Ulcerative : 2013-07-12 : Drug: Golimumab Golimumab will be administered subcutaneously. For participants weighing less than 45 kg |
| Completed |
: The Efficacy and Safety of Kappaproct in Chronic Active Treatment Refractory Ulcerative Colitis Patients : Colitis, Ulcerative : 2011-12-12 :
|
| Completed |
: GSK2982772 Study in Ulcerative Colitis Patients : Colitis, Ulcerative : 2016-09-13 :
|
| Completed |
: A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis : Colitis, Ulcerative : 2025-11-24 : JNJ-77242113 tablet will be administered orally. |
| COMPLETED |
: A Study of Vedolizumab in Adults in Real-World Practice : Colitis, Ulcerative : 2025-11-24 |
| COMPLETED |
: COlonic Salvage by Therapeutic Appendectomy. : Colitis, Ulcerative : 2025-11-24 : Surgery will be performed under general anaesthesia.The laparoscopic appendectomy can be performed with the use of 3 trocars; one subumbilical, |
| COMPLETED |
: A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC) : Colitis, Ulcerative : 2025-11-24 : As per BSA and body weight Ustekinumab will be administered SC and IV. |
| COMPLETED |
: A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) : Colitis, Ulcerative : 2025-11-24 : Vedolizumab IV infusion. |
| COMPLETED |
: To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis : Colitis, Ulcerative : 2025-11-24 : Ozanimod is an orally bioavailable, small molecule compound that activates the sphingosine 1-phosphate 1 receptor (S1P1) and the S1P 5 receptor (S1P5) |